Machine Learning Approach for the Prediction of Age-Specific Probability of SCA3 and DRPLA by Survival Curve Analysis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 6, 2022
- Accepted in final form March 23, 2023
- First Published May 4, 2023.
Author Disclosures
- Yuya Hatano, MD, PhD,
- Tomohiko Ishihara, MD, PhD,
- Sachiko Hirokawa, MS and
- Osamu Onodera, MD, PhD
- Yuya Hatano, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
<br>a Grant-in-Aid from Tsubaki Memorial Foundation<br>a Grant-in-Aid from Kyowakai Igaku Kenkyu Joseikin<br>
<br>a Grant-in-Aid from SERIKA Foundation<br> Signature: Yuya Hatano Date: 2023/03/23<br><br>
NONE
NONE
NONE
NONE
NONE
NONE
- Tomohiko Ishihara, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
<br>(1)Japan Society for the Promotion of Science, Grant-in-aid <br>for Scientific Research , 21K07272, 2021<br> Signature: Tomohiko Ishihara Date: 2023/3/23<br><br>
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sachiko Hirokawa, MS and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Osamu Onodera, MD, PhD
<br>Scientific advisory board: Kissei Pharm.<br>
NONE
<br>Speaker honoraria: Kyowa Hakko Kirin Co., Ltd., Bristol-Myers <br>Squibb, Ono Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharm, <br>Takeda, Daiichi-Sankyo, FUJIFILM, SANOFI, FP-pharm.<br>
<br>Associate editor of International Journal of Neurochemistry.<br>
<br>Association of htra1 mutations and familial ischemic cerebral <br>small-vessel disease <br>US 20120100536 A1<br>
NONE
NONE
NONE
NONE
NONE
NONE
NONE
<br>Supported in part by a Grant-in-Aid for Scientific<br>Research on Priority Areas Advanced Brain Science<br>Project and Applied Genomics; a grant from the Research<br>Committee for Hereditary Cerebral Small Vessel Diseases,<br>Research on Measures for Intractable Diseases, from the<br>Ministry of Health, Labor, and Welfare of Japan<br> Signature: Osamu Onodera Date: 2023/03/23
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence
Dr. Ishihara ishihara{at}bri.niigata-u.ac.jp
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.